Glutamate transporters (EAATs) are important to maintain spatial and temporal specificity of synaptic transmission. Their efficiency to uptake and transport glutamate into the intracellular space depends on several parameters including the intracellular concentrations of Na 1 and glutamate, the elevations of which may slow down the cycling rate of EAATs. In astrocytes, glutamate is maintained at low concentration due to the presence of specific enzymes such as glutamine synthase (GS). GS inhibition results in cytosolic accumulation of glutamate suggesting that the conversion of glutamate by GS is important for EAATs operation. Here we recorded astrocytes from juvenile rat neocortical slices and analyzed the consequences of elevated intracellular glutamate concentrations and of GS inhibition on the time course of synaptically evoked transporter current (STC). In slices from rats treated with methionine sulfoximine (MSO), a GS inhibitor, STC evoked by short burst of high frequency stimulation (HFS; 100 Hz for 100 ms) but not by low frequency stimulation (LFS; 0.1 Hz) was twice slower than STC evoked from saline injected rats. Same results were obtained for astrocytes recorded with pipette containing 3-10 mM glutamate and compared with cells recorded with 0 or1 mM glutamate in the patch pipette. We also showed that HFS elicited significantly larger NMDAR-excitatory postsynaptic currents (EPSCs) with a stronger peri/extrasynaptic component in pyramidal cells from MSO-treated compared with saline treated rats. Taken together our data demonstrate that the conversion of glutamate by GS is fundamental to ensure an efficient clearance of glutamate by EAATs and to prevent glutamate spillover. GLIA 2017;65:401-415 
Introduction
G lutamate is the main excitatory transmitter in the CNS and plays major roles in brain development and complex physiological functions, including neurogenesis, cell migration, synapse formation, learning, memory, plasticity. Dysregulation of glutamate metabolism or homeostasis has been involved in severe pathologies such as neurodegenerative diseases (amyotrophic lateral sclerosis, Alzheimer's disease, . . .) and epilepsies (Danbolt, 2001; Maragakis and Rothstein, 2004; Vandenberg and Ryan, 2013) . The influence exerted by glutamate in the brain is determined by the spatiotemporal distribution of its concentration in the extracellular space ([Glu] o ). This parameter influences the number and subtype of glutamate receptors activated by the transmitter and so the amplitude and the duration of the synaptic signal. Regulation of [Glu] o is strongly controlled by excitatory amino acid transporters (EAATs). EAATs are located at the cell surface of neurons and glial cells and they bind and transport glutamate from extracellular to intracellular spaces Danbolt, 2001; Huang and Bergles, 2004; Grewer and Rauen, 2005; Tzingounis and Wadiche, 2007; Vandenberg and Ryan, 2013) . Through these actions, EAATs preserve the responsiveness of glutamate receptors and prevent against glutamate-induced excitotoxicity. EAATs also help to maintain spatio-temporal specificity of synaptic transmission by preventing against the diffusion of glutamate release out of active synapses. Moreover, EAATs contribute to maintain a low ambient concentration of glutamate (Arnth-Jensen et al., 2002; Asztely et al., 1997; Bergles et al., 1999; Diamond, 2001; Herman and Jahr, 2007; Huang and Bergles, 2004; Marcaggi and Attwell, 2004; Takahashi et al. 1997; Tzingounis and Wadiche, 2007) . Five subtypes of EAATs have been identified so far: EAAT1/GLAST (humans/rodents) and EAAT2/GLT1 are expressed in glial cells; in the cortex GLT1 is also detected in neurons in presynaptic terminals. The three others (EAAT3/EAAC1; EAAT4; EAAT5) are expressed in neurons (Danbolt, 2001; Melone et al., 2009 ). In the cortex, neuronal glutamate transporters act primarily as a glutamate buffering system but the transport of glutamate is mainly achieved by glial cells (Diamond, 2001; Tzingounis and Wadiche, 2007; Scimemi et al., 2009) . Indeed, glial cells are responsible for the absorption and metabolism of the major part of glutamate in the brain (Danbolt, 2001 ). This is due to: (i) high glutamate transporters expression on glial cells; (ii) their very hyperpolarized resting membrane potential and low input resistance that prevent against strong depolarization. Altogether this provides favorable conditions for the translocation of glutamate into the cells (Barbour et al., 1991; Brew and Attwell, 1987; Huang and Bergles, 2004) . Another important parameter that is likely to play an important role is the intracellular glutamate concentration, which in the cytoplasm of astrocytes, is 10-to 20-fold lower than in neurons (Nedergaard et al., 2002; Zhou et al., 2014) . Different studies have demonstrated that intracellular glutamate elevation, together with Na 1 intracellular elevation, decreased glutamate transporters current evoked by exogenous application of glutamate, and affected the net number of molecules of glutamate transported (Barbour et al., 1991; Otis and Jahr, 1998) . The low intracellular glutamate concentration in astrocytes is due to several enzymes located in the cytosol and the mitochondria that rapidly catabolize the amino acid into different metabolites. In the cytosol the most important one is glutamine synthase (GS). This enzyme, which is specifically expressed by astrocytes, converts glutamate that has been taken up by glutamate transporters into glutamine in the presence of ATP and NH 3 . Reduced expression or inactivation of GS is associated with seizures in both human and rodents (Cloix et al., 2010; Eid et al., 2004 Eid et al., , 2008 Eid et al., , 2013 H€ aberle et al., 2005 . It was proposed that GS deficiency may impact on glutamate transporters operation since its inhibition leads to an accumulation of glutamate in astrocytes (Coulter and Eid, 2012; Eid et al., 2013; Laake et al., 1995; Perez et al., 2012) . Interestingly, we and others reported that a deficit in glutamate transport caused seizures in vivo and epileptical like activities in vitro in both hippocampus and neocortex suggesting a possible link between GS and EAATs (Cattani et al., 2007; Demarque et al., 2004; Milh et al., 2007; Molinari et al., 2012; Sepkuty et al., 2002; Tanaka et al., 1997) . However, evidences that GS inactivation affected glutamate transporters efficiency have not yet been provided. In the present study, we investigated this issue by measuring the time course of synaptically activated transporter current (STC) in juvenile rat neocortical astrocytes and showed that inactivation of GS slowed the decay time constant of STC evoked by short burst of high frequency stimulation and facilitated activation of peri/extrasynaptic NMDA receptors.
Materials and Methods

Slices Preparation
Experiments were performed on astrocytes and pyramidal neurons located in layer IV/V of neocortical slices obtained from postnatal day 13-16 old Wistar rats (males/females) (INMED animal facilities). Wistar rats were decapitated under chloral hydrate anesthesia (20-40 mg/kg). Brains were rapidly removed and placed in oxygenated ice-cooled artificial cerebrospinal fluid (ACSF) with the following composition (in mM): 126 NaCl, 3.5 KCl, 2 CaCl 2 , 1.3 MgCl 2 , 25 NaHCO 3 , 1.2 NaHPO 4 , and 10 glucose (95% O 2 25% CO 2 , pH 7.4). Coronal neocortical slices (400 mm thick) were obtained with a vibratome (Leica VT1200S). Following sectioning, slices were incubated in oxygenated ACSF containing 1 mM sulforhodamine 101 (SR-101) for 20 min at 348C followed by 10 min incubation in ACSF for 10 min at 348C. This procedure described by Kafitz et al. (2008) allows identifying astrocytes in slices for electrophysiological recordings. Slices were kept in ACSF at room temperature at least 1 h before used. Individual slices were then transferred to the recording chamber where they were fully submerged and superfused with ACSF at 34-358C at a rate of 4.5-5 mL/min. current, STC) using a bipolar nickel-chrome electrode positioned near the recorded astrocyte. The pipette solution used to record astrocytes and the holding potential allow minimizing the uncoupled EAAT anion current to STC. The stimulation protocol is close to that described by Diamond and Jahr (2000) and consisted to evoke STC by 5-10 stimuli at 0.1 Hz (60 ms duration, the intensity adjusted to evoke a response of 150-250 pA) corresponding to low frequency stimulation (LFS) followed by 10 stimuli at 100 Hz and 30 s latter by 11 stimuli at 100 Hz corresponding to high frequency stimulations (HFS). Each series of stimulation (0.1 Hz followed by 100 Hz) were repeated maximum 10 times when possible with an interval of 30 s. These series were numbered as serie #1, serie #2,. . . serie#10. STC elicited by high frequency stimulation (HFS) was extracted after subtracting transporter current evoked by 11 stimuli from that evoked by 10 stimuli. The response is named STC HFS whereas STC evoked at 0.1 Hz is named STC LFS . STC were recorded in continuous presence of D-(-)22-amino-5-phosphonopentaoic acid (D-AP5, 50 mM); 2,3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f ]quinoxaline-7-sulfonamide (NBQX, 20 mM); 6-imino-3-(4-methoxyphenyl)21(6H)-pyridazinebutanoic acid hydrobromide (SR95531, Gabazine, 5 mM); (2S)22-amino-2-[(1S,2S)22-carboxycycloprop-1-yl]-3-(xanth-9-yl) propanoic acid (LY341495, 1 mM);
amino-2-hydroxypropyl] (phenylmethyl)phosphinicacid hydrochloride (CGP55845A, 10 mM); nipecotic acid (1 mM), BaCl 2 (200 mM). These drugs were used to block ionotropic and metabotropic GABA and glutamate receptors, GABA transporters, and Kir channels. All these drugs were purchased from Tocris Bioscience.
Neurons were recorded in whole cell configuration with a patch electrode filled with a solution of the following composition (in mM): 130 CsGlu; 10 HEPES, 10 BAPTA, 3 Mg 21 -ATP, 0.3 Na 1 -GTP, 10 phosphocreatinine. BAPTA was used to prevent synaptic plasticity (long-term potentiation/depression). NMDAR-and AMPAR-mediated excitatory postsynaptic currents were evoked either at 0.1 Hz (NMDAR-EPSC LFS or AMPAR-EPSC LFS ) or by 10 pulses at 100 Hz (NMDAR-EPSC HFS or AMPAR-EPSC HFS ).
EPSCs were recorded in continuous presence of Gabazine (5 mM), LY341495 (1 mM) and supplemented with NBQX (20 mM) when NMDAR-EPSC were recorded or D-APV (50mM) when AMPAR-EPSC were recorded. The extracellular solution contained also high concentrations of Mg 21 and Ca 21 (6 and 4 mM, respectively) to block polysynaptic activity. All measurements were filtered at 3 kHz using an EPC-9 amplifier (HEKA Electronik), electrophysiological data were digitized (1-2 kHz) with a Digidata (Axon Instruments) interface card to a personal computer.
To measure the decay time constant, current traces were fitted with a single or a double exponential function of the following form: y 5 Afastexp(s/sfast) 1 Aslowexp(s/sslow) (where Afast and Aslow are the fractions of the fast and slow component of the current and sfast and sslow are the respective fast and slow time constant). The time constant representing the weighted average of the fast and slow components of current decay was calculated with the following equation: s 5 (sfastAfast 1 sslowAslow)/(Afast 1 Aslow). Currents were analyzed using Origin 8.0 software. Access resistance was measured from the peak of the current transient elicited by a 2 mV test pulse of 50 ms duration and applied before each EPSC LFS or STC LFS and was not compensated. The access resistance ranged between 20 and 30 M Ohm. Experiments were stopped when the resistance was increased by more than 20%. Membrane potentials of astrocytes and neurons were not corrected for liquid junction potential.
Injection of MSO
L-methionine-DL-sulfoximine (MSO, Sigma Aldrich France) was dissolved in NaCl (0.09%) and administered intraperitoneally in a dose of 170 mg/kg as previously described (Sellinger et al., 1968 ) the day before electrophysiological recordings. Sham animals were injected only with NaCl 0.09%.
HPLC Analysis for Amino Acids Levels
Twenty-four hours after the injection of MSO or NaCl, the brain was removed and coronal cortical slices were obtained as described earlier. After incubation for 1 h in ACSF at room temperature, slices were freeze-dried, dialyzed with lysis buffer (50 mM TrisHCl, 1 mM EDTA, 1% Triton; 10 mL/1 mg of tissue), sonicated and centrifuged (5 min, 15,000g at 48C). Supernatants were deproteinized with perchloric acid (0.5M, v/v) for 10 min at 48C and precipitates were spun down (10 min, 15,000g at 48C). Supernatants were collected and amino acids levels were determined using a Waters HPLC fluorometric detection system (Waters, Milford, MA). Data were computed with the Millenium software from Waters, identification and quantification of peaks were achieved by comparison with standard solutions.
Statistical Analysis
Values are indicated as mean 6 SEM. Paired Student's t-test or a one-way ANOVA with the Bonferroni post hoc test were used for comparison. Statistical analysis was performed using Origin 8.0: ns: not significant; *P < 0.05; **P < 0.01; ***P < 0.001. The number of cells used for each experiment illustrated by a figure is indicated in the legends.
Results
As already described, astrocytes can be visualized in slices with the fluorescent marker sulforhodamine 101 (SR-101), which allows to distinguish them from neurons (Kafitz et al., 2008) . Moreover, fluorescent cells displayed a linear current response to incremental depolarizing voltage steps from 2150 mV to 140 mV indicating that they are passive astrocytes (Fig. 1A,B ). In the presence of blockers of ionotropic, metabotropic GABA, and glutamate receptors, and of GABA transporters and Kir channels (see materials and methods), low frequency electrical stimulation (0.1 Hz) evoked fast inward currents that were fully blocked by DL-TBOA (100 mM), a specific blocker of glutamate transporters, indicating that they were mediated by the activation of glutamate transporters (Fig. 1B ). This inward current is referred as synaptically evoked transporter current (STC).
Partial Blockade of Glutamate Transporters Slows STC and NMDAR-EPSC Time Course
Our goal was to determine if the inactivation of GS could affect STC and evoked EPSCs. We first wondered how STC would be impacted when this uptake was artificially reduced using a low concentration of DL-TBOA (10 mM), close to the IC 50 of GLT1. We observed that TBOA reduced STC peak amplitude by 51 6 5%. In addition, the decay time constant of STC was more than two times slower than STC recorded in the absence of TBOA (Fig. 1C ). This prolonged time course did not result from the decrease in STC amplitude since in the absence of TBOA, the decay time was stable for STC evoked by a wide range of stimulus intensity (Fig.  1D ). We next analyzed the consequences of TBOA on the kinetic and charge transfer of the EPSC evoked by NMDA activation in pyramidal neurons. We observed that both the time course and charge transfer of NMDAR-EPSC were increased after the application of TBOA ( Fig. 2A,B) . We performed same analysis on AMPAR-EPSC and did not find any effects of TBOA (10 mM) on the EPSC (Fig. 2C,D) . These data are in keeping with other studies showing that NMDA but not AMPAR are impacted by the partial inhibition of EAATs unless the desensitization of AMPAR was relieved (Tzingounis and Wadiche, 2007) . According to other studies, it is likely that the selective enlargement of NMDAR-EPSC after TBOA is a consequence of an increase of glutamate diffusion and peri/extrasynaptic activation of NMDA receptors due to an insufficient uptake of glutamate by glial glutamate transporters (Arnth-Jensen et al., 2002; Diamond, 2001; Marcaggi and Attwell, 2004) . We then focused our attention on decay kinetic in the next following experiments.
Intracellular Elevation of Glutamate Concentration Affects STC Time Course Evoked by Short Burst of High Frequency Stimulation (HFS)
Immunogold electromicroscopic studies have shown that inactivation of GS with L-methionine-DL-sulfoximine (MSO) leads to intracellular accumulation of glutamate in astrocytes (Laake et al., 1995; Perez et al., 2012) . In addition the presence of Na 1 and glutamate in the cytosol may affect glutamate transport (Barbour et al., 1991; Otis and Jahr, 1998) . We thus wondered if intracellular glutamate accumulation would change STC time course. For this purpose, we recorded astrocytes with patch pipettes filled with 1, 3, 10 mM glutamate or devoid of glutamate (0 glutamate) but which contained in all cases 10 mM Na
1
. First, we measured the input resistance of the cells and observed that intracellular elevation of glutamate did not have significant consequences on this parameter (Fig. 3F) . Then, we analyzed the decay time constant of STC elicited at low frequency stimulation (0.1 Hz). No correlation between decay time constant of STC and the intracellular concentration of glutamate was observed. Indeed, the decay time of STC recorded with 1 mM glutamate in the patch pipette was similar to the one recorded with 10 mM (P 5 0.34) but the 2 values were significantly smaller than the decay of STC recorded in absence or with 3 mM glutamate in the pipette (P < 0.001, Figs. 3E and 6C). We thus assumed that intracellular glutamate elevation in astrocytes had no major consequence on glutamate uptake when the transmitter is released at low frequency. We then wondered if such conclusion would also hold true when glutamate is released during high frequency stimulation. For this purpose, we used the same experimental procedure as described by Diamond and Jahr (2000) in which STC evoked by high frequency stimulation was extracted by subtracting transporter current evoked by 11 pulses at 100 Hz to the one evoked by 10 pulses at 100 Hz and the decay time of the current (STC HFS ) compared with the one evoked at 0.1 Hz (STC LFS , Fig. 3A) . We observed that the decay time constant was slightly increased in 0-1 mM glutamate recording conditions, leading in both cases to a sdecaySTC HFS /sdecaySTC LFS ratio of 1.25 (Figs. 3B,E and 6C); this value is stronger than the one reported by Diamond and Jahr in the CA1 region of the hippocampus (ratio of 1). However, a much larger increase in STC decay time was observed in cells filled either with 3 or 10 mM glutamate, leading to a more important sdecaySTC HFS /sdecaySTC LFS ratio ( Fig. 3C-E) . These data suggested that glutamate accumulation in astrocytes may reduce glutamate uptake by the transporters particularly when the transmitter is released during a short burst of high frequency stimulation.
Glutamine Is Selectively Decreased in Cortical Slices
After Intraperitoneal Injection of MSO To determine the possible impact of GS on STC time course, MSO was administered intraperitoneally in rats 24 h before their sacrifice and the electrophysiological recordings of astrocytes in neocortical slices (see Materials and Methods section). First, to ensure that GS was inhibited, the concentration of glutamine, as well as other amino acids (glutamate, GABA, aspartate, alanine) in slices were determined by HPLC and their content (expressed in nmol/g of proteins) compared with slices from sham (saline injected) animals. As shown in Table 1 , glutamine was decreased by three times in neocortical slices from MSO treated animals as compared with slices from saline injected animals. This decrease was observed only for glutamine and the other amino acids were not significantly affected. We performed the same measurements in hippocampal slices and found that glutamine was also selectively decreased. Together, these data indicated that in vivo injection of MSO was efficient to inhibit GS, in agreement with previous studies in which the activity of GS was measured (Brusilow et al., 2010; Sellinger et al., 1968) .
The inhibition of GS can be further demonstrated electrophysiologically through the analysis of tonic NMDARmediated current in pyramidal cells that is unmasked after complete inhibition of glutamate transporters with DL-TBOA (100 mM). This current, that is insensitive to voltage gated Na 1 and Ca 21 channel blockers and to blocker of glutamate vesicular transporters or tetanus toxin, is proposed to be due to the leakage of glutamate from astrocytes Demarque et al., 2002 ; Jabaudon et al., 1999; Le Meur et al., 2007) . Different studies have demonstrated that this current is increased in pyramidal neurons from cortical slices incubated with MSO Jabaudon et al., 1999; LeMeur et al., 2007) . We tested if we can get same results in slices from MSO treated rats. In the continuous presence of TTX, and of AMPA and GABA A , receptors antagonists, application of DL-TBOA induced at 140 mV an outward current with 3 times larger density in slices from MSO-treated animals than from sham animals (Fig. 4) . This current was reversed by D-APV (50 mM, data not shown), indicating that it was mediated by NMDA receptors. Therefore, these data support that intraperitoneal injection of MSO had efficiently inhibited GS. Another important control was also to evaluate if the inactivation of GS has any consequences on transmitter release with our protocol of stimulation. Notably it was important to determine if postsynaptic responses evoked by LFS and HFS (EPSC LFS and EPSC HFS ) were stable with the iteration of the short burst at 100 Hz. Different studies have shown that GS activity is important to sustain synaptic transmission (Marx et al., 2015; Tani et al., 2010 Tani et al., , 2014 . We recorded AMPAR-mediated EPSC and performed 10 series of stimulation each consisting of 5-10 stimuli at 0.1 Hz (LFS) followed by a stimulation at 100 Hz for 100 ms (HFS), with a delay of 30 s between each series; a stimulation protocol that is close to the one used for STC. The charge transfer of AMPAR-EPSC LFS and AMPAR-EPSC HFS were expressed as percentage of the respective response evoked by LFS and HFS of the first series. There was no major variation in the synaptic response evoked by LFS and HFS in slices from saline and MSO treated rats (Fig. 5A,B) . Moreover, both the duration of the responses evoked by HFS and the ratio of the charge transfer of AMPAR-EPSC HFS/ AMPAR-EPSC LFS were stable and not significantly different in slices from the 2 groups of animal (Fig. 5B) . The decay time constant of AMPAR-EPSC LFS was also not affected in pyramidal cells from saline and MSO treated rats (saline: 5.16 6 0.5 ms; MSO 5.1 6 0.43 ms).
In separate experiments, we have also recorded spontaneous AMPAR-EPSC and did not find any differences in the MSO decreases significantly the amount of glutamine but has no effect on the other amino acids. frequency or in events amplitude (Fig. 5C ). The amplitude distribution of the events (bin of 5 pA) was similar in both groups of slice. Together our data indicated that inhibition of GS had no major consequences on spontaneous and evoked transmitter release with our stimulation protocol.
Inhibition of Glutamine Synthase by MSO Slows STC Time Course Evoked by HFS
We then determined whether GS inhibition had any consequence on STC time course. For this purpose we recorded STC with patch pipettes filled with 10 mM Na 1 and 1 mM glutamate, closed to the physiological concentrations (Chatton et al., 2000; Lebon et al., 2002; Nedergaard et al., 2002; Zhou et al., 2014) . Decay time constant of both STC LFS and STC HFS evoked during each series of stimulations were measured in neocortical astrocytes from saline and MSO treated animals. First, as for cells loaded with glutamate, inhibition of GS did not have significant consequences on input resistance of astrocytes (Fig. 6E) . Second, we observed that the decay time constant of STC HFS but not of STC LFS was significantly affected by the inactivation of GS. Thus, the decay time constant of STC HFS was about two times slower in MSO treated rats leading to a large increase in sdecaySTC HFS /sdecaySTC LFS ratio (Fig. 6A-C) . In spite of some variations this difference in current kinetic was maintained when stimulations were repeated. We have also measured the charge transfer of STC LFS and STC HFS . We observed that for similar values of STC LFS , there was also no difference in the charge transfer of STC HFS in astrocytes from both groups of rat (Fig. 6D) . Together, our data suggest that same amount of glutamate is reuptake by glutamate transporters but this takes longer time in astrocytes inactivated for GS when glutamate is released by HFS.
Inhibition of GS Increases Peri/Extrasynaptic Activation of NMDA Receptors
The increase in STC HFS decay time constant in astrocytes inactivated for GS suggested that glutamate transporters close to synaptic sites are overwhelmed by glutamate released during HFS. This should facilitate the spillover of the transmitter out of the synaptic cleft and the activation of NMDA receptors located at peri/extrasynaptic sites leading to an amplification of NMDAR-mediated EPSC evoked by HFS. We tested this hypothesis and recorded NMDAR-mediated EPSC. We calculated the ratio of the charge transfer of NMDAR-EPSC HFS /NMDAR-EPSC LFS for each series of stimulation in pyramidal neurons from both MSO and saline injected rats as we did for AMPAR-EPSC. Figure 7A -C shows that the ratio was consistently and significantly stronger in pyramidal neurons from MSO treated rats. On average, the charge transfer of NMDAR-EPSC HFS was stronger in these pyramidal neurons while NMDAR-EPSC LFS was even slightly lower compared with the values of pyramidal neurons from saline treated rats (Fig. 7C) . Also, in line with the absence of effects of GS inhibition on STC LFS decay time constant, the time course of NMDAR-EPSC LFS was not significantly different in pyramidal neurons from the 2 groups of rat (Fig. 7D) . We next examined the peri/extrasynaptic NMDA component of NMDAR-EPSC HFS (Fig. 7E-G) . This component was isolated from the synaptic response using the irreversible NMDA open channel blocker MK-801 (40 mM). After 5 min of stimulation at 0.1 Hz, MK-801 (40 mM) was installed until the full abolishment of the response. MK-801 was then washed out and HFS (same stimulation as above) was applied every minutes. These stimulations consistently evoked a response with a slow onset that was fully abolished by D-APV (50 mM) indicating that they were mediated by peri/ extrasynaptic NMDA receptors (Fig. 7E) . However, we cannot fully exclude a contribution of some synaptic NMDA receptors to the response because HFS may recruit additional synaptic connections that were not active during application of LFS in MK801. We calculated the charge transfer of the NMDARs mediated response after MK801 (extrasynaptic response) normalized to the charge transfer before the application of the blocker (synaptic response) in pyramidal neurons from the two groups of rat. The responses were significantly stronger in MSO treated animal (Fig. 7F,G) . On an average, the responses evoked by extrasynaptic receptors during the 10 series of HFS were 45% larger in MSO treated animals while synaptic NMDAR-EPSC LFS preceding the application of MK-801 were not different in the two groups of animal.
Discussion
Electron microscopy studies performed in the somatosensory cortex demonstrated that most of glutamate transporters are present in astrocytic processes and have a prominent perisynaptic localization that may contribute to restrict glutamate spillover (Melone et al., 2009 ). Moreover, a recent study provided evidences that GLT1 in astrocytes are highly mobile and that once bound by glutamate, they move away from the synapse allowing their replacement by unbound transporters, a process that may favor efficient clearance of glutamate from synaptic cleft (Murphy-Royal et al., 2015) . Here, we show that these characteristics may be insufficient for a rapid clearance of glutamate when glutamate catabolism in astrocytes is altered. We provide evidences that GS activity regulates STC time course when glutamate is released by short burst of high frequency stimulation but not by low frequency stimulation. This indicated that the conversion of glutamate by GS is a fundamental process for proper glutamate transporters function. It is likely that the consequences of GS inactivation result from an intracellular accumulation of glutamate occurring with the stimulations, since the slowing of STC time course was also observed in the same stimulation conditions of astrocytes recorded with 3-10 mM glutamate. The tendency of glutamate to accumulate in astrocytes in the absence of GS activity has been demonstrated in both hippocampal astrocytes and M€ uller cells of the retina with immunogold labelling (Barnett et al., 2000; Laake et al., 1995; Perez et al., 2012) , and with electrophysiological recordings of endogenous NMDA current in CA1 pyramidal neurons unmasked after inhibition of glutamate transporters Demarque et al., 2002; Jabaudon et al., 1999 ; Le can be viewed at wileyonlinelibrary.com] that GS is a major enzyme involved in glutamate catabolism. In line with this, metabolic studies have shown that two-third of glutamate released and transported in astrocytes is converted by GS into glutamine whereas one-third is transported into mitochondria and converted to alpha-ketoglutarate (Hertz and Zielke, 2004) . The prolongation of STC time course observed after GS inhibition reflects a delayed clearance of extracellular glutamate and to a potent diffusion of the transmitter at distant sites as demonstrated by a larger peri/extrasynaptic NMDA response elicited by HFS in MSO compared with saline injected animals. Moreover, the observations that low concentration of TBOA prolonged the decay time constant of both STC LFS and NMDAR-EPSC LFS support the relationship between STC time course on one hand, and the kinetic of the NMDA response on the other hand, and indicate that glutamate transporters in astrocytes limit NMDA receptors activation at a juvenile stage (see also Hanson et al., 2015) . We cannot exclude that neuronal glutamate transporters could also play an important role in shaping the NMDA response, as demonstrated in the CA1 region of the hippocampus (Diamond, 2001; Scimemi et al., 2009 ) but this was not investigated in the present study. Here, pyramidal cells were recorded at 140 mV a condition, which is not favorable for glutamate transport by neuronal glutamate transporters.
It has been suggested that intracellular ionic composition influences the cycling or turnover rate of glutamate transporters. As mentioned by Huang and Bergles (2004) and by Wadiche et al. (2006) , the turnover rate of glutamate transporters of the same identity can vary from a preparation to another. Thus, the turnover rate of GLT1 in hippocampal astrocytes measured in outside-out patch configuration is about 11 ms at 290 mV (Bergles and Jahr, 1998) whereas intracellular recording of transporter current in oocytes expressing GLT1 and that contain 10 mM glutamate and 10 mM Na 1 showed that this rate was about 70 ms (Wadiche et al., 1995) . It is therefore possible that GS inhibition through intracellular glutamate accumulation, and in presence of Na 1 , slow down the cycling rate of transporters and affects the capture efficiency i.e., the likelihood of glutamate to be translocated and released intracellularly as opposed to unbind extracellularly. Indeed, experimental data on the uncoupled anion transporter current and simulations suggest that before the final intracellular unbinding of glutamate and Na 1 , glutamate transporter seesaw between 2 states in which both ions are bind to the external face and to the internal face of the transporter, glutamate translocation forward and backward rates are almost equal for GLT1 (Bergles et al., 2002) . In the presence of Na 1 and glutamate inside, the transporter has higher probability to keep bouncing between these 2 states delaying the intracellular unbinding of glutamate and Na 1 , the reorientation of the transporter to the outside by the intracellular K 1 ions and thus the possibility for the transporter to uptake another molecule of glutamate from the extracellular space. This mechanism could reduce the capacity of glutamate transporters near synaptic sites to rapidly uptake glutamate when released by HFS and favor diffusion of the transmitter to glutamate transporters at distant sites. This may explain the prolongation of STC HFS time course. Therefore, maintaining low glutamate concentration (and also Na 1 ) in cytosol may be instrumental for astrocytes to efficiently clear glutamate released under certain circumstances of activation.
The actual resting concentration of glutamate in cortical astrocytes seems to range between 0.5 and 1 mM in rodent (Nedergaard et al., 2002; Zhou et al., 2014) and was estimated to be around 0.7 mM in human (Lebon et al., 2002) . It is however not known how long it takes for glutamate after its transport in astrocytic process to reach back to this basal concentration. This may take longer time when GS is inhibited favoring glutamate accumulation. In physiological condition, the conversion of glutamate may be certainly fast enough since the decay time of STC HFS was close to that of STC LFS in astrocytes from saline injected rat during the different series of stimulation or in astrocytes recorded without glutamate in the patch pipette. However, we found that the ratio of the decay time constant of STC HFS /STC LFS was 1.25. This value differs from what was observed in the CA1 region of the hippocampus from juvenile rats, where Diamond and Jahr (2000) found a ratio of 1. This suggests that neocortical astrocytic glutamate transporters close to synaptic sites would be less efficient to uptake glutamate released by HFS than those from the hippocampus. Interestingly, it was recently shown that astrocyte glutamate transporters mature later in the neocortex than in the hippocampus (Hanson et al., 2015) . Immunofluorescence studies showed that GLT1 and GLAST are 40% less expressed in the neocortex than in the hippocampus from juvenile rats (Hanson et al., 2015) . These authors provide also evidences that transporter current evoked by glutamate photolysis, decays slower in the neocortex than in the hippocampus until the third postnatal weeks of life. In keeping with this, the time course of STC recorded in the present study was also slower than the one previously reported in hippocampal astrocytes at the same developmental stage (Thomas et al., 2011) . In addition, a study that has just been published while this article was revised showed that the efficiency of glutamate uptake in the adult mice neocortex was modulated by presynaptic activity but by a process that is independent of the amount of glutamate released. The clearance of glutamate is slowed when glutamate is released by burst of neuronal activity >30 Hz and particularly by 10 stimuli at 100 Hz (Armbruster et al., 2016) . These observations, if this hold true in rat at juvenile stage, could also explain the ratio >1 of the decay time constant of STC HFS / STC LFS obtained here.
It has been shown in different preparations that the activity of GS is fundamental for synaptic transmission (Marx et al., 2015) . This enzyme converts glutamate into glutamine, which is released by astrocytes and taken up by neurons where it is converted into glutamate by the phosphate activated glutaminase (Coulter and Eid, 2012; Marx et al., 2015) . Our data show that synaptic transmission mediated by AMPA receptors are not impacted by the inactivation of GS. More precisely, the charge transfer of EPSC evoked by LFS and HFS as well as the ratio of EPSC HFS /EPSC LFS were relatively constant with the iteration of the 100 Hz stimulation and not different from the results obtained from saline treated rats. In addition, the mean charge transfer of both STC LFS and STC HFS were not different in the two groups of rat. These data suggest that GS activity is not necessary to sustain glutamate synaptic transmission in the neocortex. These results apparently disagree the conclusion of Tani et al. (2010 Tani et al. ( , 2014 about the requirement of glutamate/glutamine cycle to sustain glutamate synaptic transmission in neocortex. The most likely explanation for this discrepancy is the experimental procedure and the situation of high demand of glutamate resulting from persistent epileptiform activity (Tani et al., 2010) or from the protocol of stimulation used by Tani et al. (2014) i.e., iteration of intermittent stimulation at 20 Hz for 40 s separated by stimulation at 0.2 Hz. Our procedure is certainly not sufficiently strong to deplete vesicles pools of glutamate as was the case in the experiments of Tani et al. (2014) and for which the synthesis of glutamate from glutamine may be important to replenish the pool of glutamate in presynaptic terminals. In our condition, the delay between 2 bursts of HFS and 2 series of stimulation were of 30 s. This delay may allow expression of alternatives mechanism of recycling via glutamine i.e., other metabolic pathways and presynaptic uptake of glutamate via GLT-1 (Marcaggi and Attwell, 2004; Marx et al., 2015; Danbolt et al., 2016) . We cannot however fully exclude in our situation that the residual amount of glutamine in slices from MSO treated rats could also help maintaining synaptic transmission.
The importance of GS for cortical network activity and brain development is highlighted by the deleterious effects of mutations in the human GLUL gene that encodes GS, leading to a strong inactivation of GS and associated with severe brain malformations, with seizures, and with early epileptic encephalopathy (H€ aberle et al., 2005, 2011) . In rodent, mice lacking GS in astrocytes die rapidly after birth (He et al., 2010) . Moreover, different studies have shown that the reactive astrocytes seen in a variety of pathological conditions including mesial temporal lobe epilepsy, do not express GS (Coulter and Eid, 2012; Eid et al., 2013) . A defect in GS activity may have various consequences due to an increase in ammonia concentration in the brain and to the lack of glutamine synthesis leading to a reduction of GABAergic inhibition (He et al., 2010; Kelly et al., 2009; Liang et al., 2006; Ortinski et al., 2010) , which may contribute to the generation of seizures. The delayed clearance and spillover of glutamate described in the present study, following a pattern of stimulation that could also happen during seizures, is likely to contribute to the maintenance of a hyperexcitable state. The possibility that this mechanism is actually operating in epilepsy will be investigated in future studies in the appropriate animal model and will help to clarify the electrophysiological consequences of a dysregulation of glutamate catabolism and homeostasis that is associated with some epileptic disorders.
